These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 6438979)

  • 1. Cyclosporin A serum and blood levels in marrow graft recipients: correlation with administered dose, serum creatinine and graft-versus-host disease.
    Bacigalupo A; Di Giorgio F; Frassoni F; Van Lint MT; Raffo MR; Gogioso L; Viale M; Marmont AM
    Acta Haematol; 1984; 72(3):155-62. PubMed ID: 6438979
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Nephrotoxicity in bone marrow transplant recipients treated with cyclosporin A.
    Hows JM; Chipping PM; Fairhead S; Smith J; Baughan A; Gordon-Smith EC
    Br J Haematol; 1983 May; 54(1):69-78. PubMed ID: 6342656
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cyclosporin A in marrow transplantation for leukemia and aplastic anemia.
    Bacigalupo A; Frassoni F; van Lint MT; Raffo MR; Vitale V; Corbetta G; Chierichetti S; Marmont AM
    Exp Hematol; 1985 May; 13(4):244-8. PubMed ID: 3886417
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cyclosporine in human bone marrow transplantation. Serum concentration, graft-versus-host disease, and nephrotoxicity.
    Gratwohl A; Speck B; Wenk M; Forster I; Müller M; Osterwalder B; Nissen C; Follath F
    Transplantation; 1983 Jul; 36(1):40-4. PubMed ID: 6346614
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Oral administration of cyclosporin A for recipients of allogeneic marrow transplants: implications of clinical gut dysfunction.
    Atkinson K; Biggs JC; Britton K; Short R; Mrongovius R; Concannon A; Dodds A
    Br J Haematol; 1984 Feb; 56(2):223-31. PubMed ID: 6362711
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cyclosporin-A in allogeneic bone marrow transplantation for leukemia: Basle experience 1979 to 1984.
    Gratwohl A
    Tokai J Exp Clin Med; 1985 Jun; 10(2-3):127-32. PubMed ID: 3914737
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cyclosporin A associated nephrotoxicity in the first 100 days after allogeneic bone marrow transplantation: three distinct syndromes.
    Atkinson K; Biggs JC; Hayes J; Ralston M; Dodds AJ; Concannon AJ; Naidoo D
    Br J Haematol; 1983 May; 54(1):59-67. PubMed ID: 6342655
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Correlation between low CSA plasma concentration and severity of acute GvHD in bone marrow transplantation.
    Schmidt H; Ehninger G; Dopfer R; Blaurock M; Naumann R; Einsele H; Haen M; Schüch K; Jaschonek K; Niethammer D
    Blut; 1988 Sep; 57(3):139-42. PubMed ID: 3046689
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Dermatological aspects of the use of Cyclosporin A for prophylaxis of graft-versus-host disease.
    Harper JI; Kendra JR; Desai S; Staughton RC; Barrett AJ; Hobbs JR
    Br J Dermatol; 1984 Apr; 110(4):469-74. PubMed ID: 6370294
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Differential diagnosis of Cyclosporin A nephrotoxicity versus rejection by fine needle aspiration biopsy.
    Häyry P; von Willebrand E; Ahonen J
    Proc Eur Dial Transplant Assoc; 1983; 20():356-61. PubMed ID: 6361749
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Minimal risk of chronic renal dysfunction in marrow transplant recipients treated with cyclosporine for 6 months.
    Yee GC; McGuire TR; St Pierre BA; Self SG; Zager RA; Sullivan KM; Deeg HJ
    Bone Marrow Transplant; 1989 Nov; 4(6):691-4. PubMed ID: 2684309
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Serum cyclosporine concentration and risk of acute graft-versus-host disease after allogeneic marrow transplantation.
    Yee GC; Self SG; McGuire TR; Carlin J; Sanders JE; Deeg HJ
    N Engl J Med; 1988 Jul; 319(2):65-70. PubMed ID: 3288872
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [How long should cyclosporin be administered following bone marrow transplantation?].
    Gratwohl A; Tichelli A; Stauffer G; Passweg J; Pless M; Gengenbacher D; Buser U; Signer E; Haberthür C; Gimmi C
    Schweiz Med Wochenschr; 1994 Jan; 124(1-2):44-50. PubMed ID: 8296190
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of cyclosporin A on the anti-leukaemia action associated with graft-versus-host disease.
    Denham S; Attridge S; Barfoot RK; Alexander P
    Br J Cancer; 1983 Jun; 47(6):791-5. PubMed ID: 6344898
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A pilot study of low-dose cyclosporin for graft-versus-host prophylaxis in marrow transplantation.
    Stockschlaeder M; Storb R; Pepe M; Longton G; McDonald G; Anasetti C; Appelbaum F; Doney K; Martin P; Sullivan K
    Br J Haematol; 1992 Jan; 80(1):49-54. PubMed ID: 1536809
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prolactin: a possible mediator of graft-versus-host disease following allogeneic bone marrow transplantation in humans.
    Hinterberger-Fischer M; Kier P; Spona J; Sebesta C; Tiefengraber E; Habertheuer KH; Ruckser R; Schmid A; Kalhs P; Lechner K
    Bone Marrow Transplant; 1994 Sep; 14(3):403-6. PubMed ID: 7994262
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Ciclosporin A: correlation of blood levels with acute graft-versus-host disease after bone marrow transplantation.
    Bandini G; Strocchi E; Ricci P; Rizzi S; Boschi S; Guardigli C; Calori E; Motta MR; Giudice V; Rosti G
    Acta Haematol; 1987; 78(1):6-12. PubMed ID: 3116813
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cyclosporin-A deposits in renal allografts.
    von Willebrand E; Häyry P
    Lancet; 1983 Jul; 2(8343):189-92. PubMed ID: 6135029
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Renal toxicity after allogeneic bone marrow transplantation: the combined effects of total-body irradiation and graft-versus-host disease.
    Miralbell R; Bieri S; Mermillod B; Helg C; Sancho G; Pastoors B; Keller A; Kurtz JM; Chapuis B
    J Clin Oncol; 1996 Feb; 14(2):579-85. PubMed ID: 8636774
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Renal side effects of high and low cyclosporin A doses in patients with rheumatoid arthritis.
    Berg KJ; Førre O; Djøseland O; Mikkelsen M; Narverud J; Rugstad HE
    Clin Nephrol; 1989 May; 31(5):232-8. PubMed ID: 2661065
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.